7Baggers
 BeyondSpring Inc. Reports Q3 2025 Earnings and Strategic Shift  TipRanks Sat, 15 Nov 2025 04:19:26 GMT
 BeyondSpring (NASDAQ:BYSI) Issues Quarterly Earnings Results  MarketBeat Thu, 13 Nov 2025 20:19:40 GMT
 BeyondSpring reports Q3 EPS (4c) vs (5c) last year  TipRanks Wed, 12 Nov 2025 23:18:23 GMT
 beyondspring inc. (bysi) reports q3 loss of $0.05  StreetInsider Wed, 12 Nov 2025 13:08:49 GMT
 BeyondSpring's Plinabulin Shows Promise in Cancer Treatment  GuruFocus Wed, 12 Nov 2025 12:45:12 GMT
 Drugmaker BeyondSpring's Q3 net loss narrows to $1.7 mln  MarketScreener Wed, 12 Nov 2025 12:11:16 GMT
 beyondspring (nasdaq:bysi) trading down 2.4% - time to sell?  MarketBeat Thu, 06 Nov 2025 05:40:12 GMT
 published on: 2025-11-05 22:15:00  newser.com Thu, 06 Nov 2025 04:15:00 GMT
 BeyondSpring (NASDAQ:BYSI) Trading Down 2.4% - Time to Sell?  MarketBeat Wed, 05 Nov 2025 08:00:00 GMT
 published on: 2025-11-04 04:07:19  newser.com Tue, 04 Nov 2025 10:07:19 GMT
 published on: 2025-11-02 11:57:20  newser.com Sun, 02 Nov 2025 16:57:20 GMT

BeyondSpring Inc
(NASDAQ:BYSI) 

BYSI stock logo

BeyondSpring Inc., a clinical stage biopharmaceutical company, together with its subsidiaries, focuses on the development and commercialization of immuno-oncology cancer therapies. The company's lead asset is the Plinabulin that is in late stage clinical trials as an anti-cancer agent in combination...

Founded: 2010
Full Time Employees: 61
Sector: Healthcare
Industry: Biotechnology

Share this website to your friends